New Delhi. Artificial Intelligence (AI) can change the face of the medical world in the coming decade. Anthropic CEO Dario Amadei has claimed that if AI technology is used in the right direction, cancer, Alzheimer's, heart disease and mental illnesses could be a thing of the past in the next 10 years. According to him, with the help of AI, the time taken for medical research and discovery of new medicines can be significantly reduced.
Amadei said he expects extraordinary advances will be made in treating cancer, Alzheimer's, heart disease and mental illnesses in less than a decade. He said that with proper use of AI, such a time can come when humanity will be able to find solutions to those problems which have been considered challenges for centuries.
Other giants in the AI field have also expressed hope
Amadei isn't the only one optimistic about the potential for AI in the medical field. Elon Musk and Google's AI chief Demis Hassabis also consider this technology as a medium for major changes in health services and drug research.
What is Elon Musk's claim?
Elon Musk is also very excited about the use of AI in the medical field. He believes that with the help of AI, better medical facilities can also be available to common people in the future. This is expected to bring a big change in the quality and accessibility of health services.
Hasabis said – time taken to search for medicines will be reduced
Google AI chief Demis Hassabis believes that AI can reduce the time taken for drug discovery from years to a few weeks. He has given the example of Google's AI based protein research model 'Alphafold'. This technique has played an important role in predicting more than 20 crore protein structures.
AlphaFold's achievement demonstrates the potential of AI in biological research. This has helped scientists understand the structure of proteins and conduct research to develop new drugs.
Pharma experts raised questions on the claims
However, not all experts in the pharmaceutical industry agree with these claims of the heads of AI companies. Jeff Leyden, executive chairman of Vertex Pharmaceuticals, called timelines such as the end of the disease unrealistic.
According to him, Vertex, in collaboration with about 50 AI companies, tested 10,000 drug compounds, but none of them could develop an effective medicine on their own. This clearly shows that despite the potential in AI, a lot of work still remains to be done to solve the complex challenges of the medical field.
Even after making the medicine, investigation continues for years
According to medical experts, even if a potential medicine is discovered faster with the help of AI, the process of delivering it to patients is not easy. Before any new medicine gets permission for use, it is necessary to test its safety and effectiveness.
For this, laboratory research, pre-clinical testing and clinical trials are conducted in several phases on humans. These trials may take several years. Therefore, just by accelerating the discovery of medicines, immediate treatment of diseases does not become possible.
At present AI is being seen as a helpful technology in medical research. It can help scientists discover new drugs, identify diseases, and understand biological processes. However, the claim of completely eliminating serious diseases like cancer and Alzheimer's in the next 10 years is still a possibility and a guess, not an established scientific conclusion.